Latest Breaking News On - Nuvectis pharma daily - Page 2 : vimarsana.com

Nuvectis Pharma, Inc (NASDAQ:NVCT) Major Shareholder Buys $135,771 16 in Stock

Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Free Report) major shareholder Marlio Charles Mosseri acquired 9,149 shares of the firm’s stock in a transaction dated Tuesday, July 18th. The stock was bought at an average cost of $14.84 per share, with a total value of $135,771.16. Following the acquisition, the insider now owns 2,563,762 shares in […]

Marlio charles mosseriNuvectis pharmaNuvectis pharma incVanguard group incCitadel advisorsGeode capital managementBaldwin brothersEdmond de rothschild holdingGet free reportCharles mosseriCapital managementNuvectis pharma dailyNasdaq nvctInsider tradingNsider trades

Nuvectis Pharma, Inc (NASDAQ:NVCT) Major Shareholder Purchases $135,920 12 in Stock

Nuvectis Pharma, Inc (NASDAQ:NVCT) Major Shareholder Purchases $135,920 12 in Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Marlio charles mosseriNuvectis pharmaGeode capital managementNuvectis pharma incBlackrock incEdmond de rothschild holdingNuvectis pharma company profileGet free reportCharles mosseriPharma trading downStreet groupStreet corpCapital managementNuvectis pharma daily

Marlio Charles Mosseri Purchases 8,948 Shares of Nuvectis Pharma, Inc (NASDAQ:NVCT) Stock

Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Free Report) major shareholder Marlio Charles Mosseri bought 8,948 shares of the business’s stock in a transaction dated Friday, July 7th. The shares were acquired at an average cost of $15.19 per share, for a total transaction of $135,920.12. Following the transaction, the insider now directly owns 2,541,328 shares […]

Marlio charles mosseriNuvectis pharmaNuvectis pharma incBlackrock incEdmond de rothschild holdingSecurities exchange commissionGeode capital managementGet free reportExchange commissionCharles mosseriPharma stock downStreet groupStreet corpCapital managementNuvectis pharma dailyNasdaq nvct

Insider Buying: Nuvectis Pharma, Inc (NASDAQ:NVCT) Major Shareholder Purchases $18,251 52 in Stock

Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) major shareholder Marlio Charles Mosseri acquired 1,176 shares of the business’s stock in a transaction dated Wednesday, July 5th. The stock was bought at an average cost of $15.52 per share, with a total value of $18,251.52. Following the acquisition, the insider now owns 2,529,201 shares in the […]

Marlio charles mosseriNuvectis pharmaNuvectis pharma incVanguard group incCitadel advisorsBaldwin brothersEdmond de rothschild holdingGeode capital managementFree reportCharles mosseriCapital managementNuvectis pharma daily

Nuvectis Pharma, Inc (NASDAQ:NVCT) Shares Purchased by Baldwin Brothers LLC MA

Baldwin Brothers LLC MA increased its position in shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) by 7.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 143,800 shares of the company’s stock after acquiring an additional 10,500 shares […]

Marlio charles mosseriNuvectis pharmaTower research capitalNuvectis pharma incBlackrock incVirtu financialSecurities exchange commissionNuvectis pharma company profileBaldwin brothersVanguard group incFree reportResearch capitalStreet corpVanguard groupExchange commissionVisit holdingschannel